Worldwide is the Max Planck Institute of Psychiatry considered as one of the leading research institutes on psychiatry. Medical doctors and psychologists as well as basic researchers of all natural sciences work together for the understanding and subsequent development of future therapeutic options for psychiatric and neurological diseases.
A modern technical research platform allows the identification of disease related genetic and epigenetic factors. Genom-wide analysis of the heritable information (Genomics) as well as cell or tissue protein content analysis (Proteomics) are done. Animal models allow the molecular biological, cell biological and behavioral analyses of factors to get insight and proof of scientific hypotheses.
400 patients participate in different clinical trails each year. Extensive phenotyping of the patients with analysis of blood and liquor samples, clinical psychopathology and neuropsychological testing, neurophysiological methods, neuroimaging techniques, as well as protein and gene analyses form the basis to investigate the causation of complex psychiatric and neurological diseases.
Close to 600 people are working at the Max Planck Institute of Psychiatry. The researchers are organised in 14 preclinical and 15 clinical reearch groups, which are focussing on the following topics:
- Depression & Anxiety
- Mental Health Span
- Internal Medicine
- History of Medicine